G-1639A but Not C1173TVKORC1Gene Polymorphism Is Related to Ischemic Stroke and Its Various Risk Factors in Ukrainian Population
Open Access
- 15 September 2016
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2016, 1-10
- https://doi.org/10.1155/2016/1298198
Abstract
Vitamin K epoxide reductase complex subunit 1 (VKORC1) is integral 163-amino acid long transmembrane protein which mediates recycling of vitamin K 2,3-epoxide to vitamin K hydroquinone and it is necessary for activation of vitamin K-dependent proteins (VKDPs). Herein, the association between G-1639A (rs9923231) and C1173T (rs9934438) single-nucleotide polymorphisms (SNPs) of theVKORC1gene and ischemic stroke (IS) was tested in Ukrainian population. Genotyping was performed in 170 IS patients and 124 control subjects (total 294 DNA samples) using PCR-RFLP (polymerase chain reaction with following restriction fragment length polymorphism analysis) method. Our data showed that G-1639A but not C1173T polymorphism was related to IS, regardless of adjustment for age, sex, body mass index, smoking status, and arterial hypertension. The risk for IS in -1639A allele carriers (OR = 2.138,) was higher than in individuals with G/G genotype. Haplotype analysis demonstrated that -1639G/1173T and -1639A/1173C were related to increased risk for IS (OR = 3.813,and OR = 2.189,, resp.), while -1639G/1173C was a protective factor for IS (OR = 0.548,). Obtained results suggested that -1639A allele can be a possible genetic risk factor for IS in Ukrainian population.
Keywords
Funding Information
- Ministry of Education and Science of Ukraine (0115U000688)
This publication has 29 references indexed in Scilit:
- Growth Arrest-Specific Gene 6 (gas6) and Vascular HemostasisAdvances in Nutrition: An International Review Journal, 2012
- Lack of association between variants in theVKORC1gene and cerebrovascular or coronary heart diseaseJournal of Thrombosis and Haemostasis, 2008
- Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirementBlood, 2008
- Single nucleotide polymorphisms in the VKORC1 gene and the risk of stroke in the Southern German populationThrombosis and Haemostasis, 2008
- No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial diseaseThrombosis and Haemostasis, 2008
- Common VKORC1 variants are not associated with arterial or venous thrombosisJournal of Thrombosis and Haemostasis, 2007
- VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection)Circulation, 2006
- A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivityHuman Molecular Genetics, 2005
- Identification of the gene for vitamin K epoxide reductaseNature, 2004
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993